GLP-1 Receptor Agonists: Clinical Evidence and Patient Outcomes
GLP-1 Clinical Relevance #42Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical CommentaryObservational ResearchWeight LossGLP-1 Receptor AgonistPrimary CareAdults…
Tirzepatide Cardiovascular Safety: Clinical Trial Evidence
GLP-1 Clinical Relevance #30Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical ReviewComparative Efficacy StudyCardiovascular OutcomesTirzepatideEndocrinologyAdults…
Medical Cannabis Authorization Linked to Modestly Higher Heart Failure Risk in Large Ontario Study
Patients exposed to cannabis had a higher risk for the primary outcome with a hazard ratio of 1.15 (95% CI: 1.06–1.25). The results suggest a higher risk of heart failure-related events, including emergency department visits, hospitalizations, and…
CBD Gummies and Heart Health: What the Evidence Really Shows for Everyday Use
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CardiovascularCbdDrug…
26-CCC-18139-ACC ARRHYTHMOGENIC POTENTIAL OF SYNTHETIC CANNABIS – JACC
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CardiologySynthetic…
Specific Forms of Substance Misuse Increase Stroke Risk – Psychiatry Advisor
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Stroke RiskSubstance UseCardiovascular…